This inventor holds 1 USPTO granted patent. Top assignee: Institut De Cardiologie De Montreal. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Romain Ferru-Clément and His Patent on Inflammatory Bowel Disease Biomarkers.
Introduction
Romain Ferru-Clément is an inventor associated with Poitiers, France. His patent work concerns lipid biomarkers that may support the diagnosis and monitoring of inflammatory bowel disease.
Latest Patents
Ferru-Clément is associated with 1 patent, titled “Metabolic Biomarkers of Inflammatory Bowel Disease.” The disclosure describes lipid biomarkers related to inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis. It also addresses biomarkers that may indicate disease location or behavior. Proposed uses include diagnosing inflammatory bowel disease, assessing predisposition, monitoring disease progression or regression, and evaluating the efficacy of treatments.
Career Highlights
The available information associates Ferru-Clément with the Institut de Cardiologie de Montréal. His patent reflects research into metabolic indicators and their potential applications in understanding and managing inflammatory bowel disease.
Collaborations
John D. Rioux is identified as a coworker. The patent’s subject matter connects their professional context with research into biomarkers and inflammatory bowel disease.
Conclusion
Romain Ferru-Clément’s patent focuses on potential lipid biomarkers and methods for applying them to the diagnosis, assessment, and monitoring of inflammatory bowel disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile